These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 33590941
1. Development and validation of point-of-care testing of albuminuria for early screening of chronic kidney disease. Vutthikraivit N, Kiatamornrak P, Boonkrai C, Pisitkun T, Komolpis K, Puthong S, Lumlertgul N, Peerapornratana S, Thanawattano C, Tungsanga S, Praditpornsilpa K, Tungsanga K, Eiam-Ong S, Srisawat N. J Clin Lab Anal; 2021 Apr; 35(4):e23729. PubMed ID: 33590941 [Abstract] [Full Text] [Related]
2. Chronic kidney disease in type 2 diabetes: Does an abnormal urine albumin-to-creatinine ratio need to be retested? Garg D, Naugler C, Bhella V, Yeasmin F. Can Fam Physician; 2018 Oct; 64(10):e446-e452. PubMed ID: 30315036 [Abstract] [Full Text] [Related]
4. Diagnostic accuracy of semiquantitative point of care urine albumin to creatinine ratio and urine dipstick analysis in a primary care resource limited setting in South Africa. Currin SD, Gondwe MS, Mayindi NB, Chipungu S, Khoza BL, Tollman S, Fabian J, George JA, ARK Consortium. BMC Nephrol; 2021 Mar 20; 22(1):103. PubMed ID: 33743616 [Abstract] [Full Text] [Related]
7. Sensitive and accurate monitoring of urinary albumin and point-of-care testing using a fluorescent probe with anti-interference capacity against exogenous drugs. Lu C, Xu L, Jiang Y, Liao C, Li Y, Tang Y, Xu Z, Du X, Lv T, Wang Y, Qin T, Liu B, Zhu M. Talanta; 2024 Nov 01; 279():126575. PubMed ID: 39024852 [Abstract] [Full Text] [Related]
10. A sensitive immunoblotting method for screening of microalbuminuria in diabetic patients' urine. Abdolkhaleg D, Behrooz S. Saudi Med J; 2005 Jul 01; 26(7):1075-9. PubMed ID: 16047056 [Abstract] [Full Text] [Related]
13. Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study. van Mil D, Kieneker LM, Evers-Roeten B, Thelen MHM, de Vries H, Hemmelder MH, Dorgelo A, van Etten RW, Heerspink HJL, Gansevoort RT. Lancet; 2023 Sep 23; 402(10407):1052-1064. PubMed ID: 37597522 [Abstract] [Full Text] [Related]